Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis–Experienced Gay and Bisexual Men in Australia

Willingness to use daily antibiotic for sexually transmitted infection preexposure prophylaxis was found among half of Australian HIV preexposure prophylaxis–experienced gay and bisexual men in our study. Background Gay and bisexual men (GBM) who use HIV preexposure prophylaxis (HIV-PrEP) have high rates of bacterial sexually transmitted infections (STIs). The use of daily antibiotics as STI preexposure prophylaxis (STI-PrEP) may be appealing to GBM who are using or have previously used HIV-PrEP (HIV-PrEP–experienced) for the prevention of bacterial STIs. Methods We examined willingness to use daily STI-PrEP among a cross-sectional sample of HIV-PrEP–experienced GBM in Australia who participated in an observational online cohort study from August 2018 to March 2020. Factors associated with willingness to use daily STI-PrEP were determined using bivariate and multivariate logistic regression. Results Of the 1347 participants, half (54.3%) were willing to use daily STI-PrEP. Factors independently associated with greater willingness to use daily STI-PrEP included having >10 sexual partners in the last 6 months, using methamphetamine in the last 6 months, being more conscious about avoiding STIs, having a greater number of STIs since commencing HIV-PrEP, being willing to take HIV-PrEP for as long as they were at risk of acquiring HIV, and only using condoms when a sexual partner requested them. Conversely, factors associated with less willingness to use daily STI-PrEP included being university educated, using nondaily dosing regimens of HIV-PrEP, preferring event-driven HIV-PrEP, and being concerned about long-term HIV-PrEP adverse effects. Conclusions Sexually transmitted infection PrEP is likely to be appealing to many HIV-PrEP–experienced GBM, especially those who engage in activities associated with a higher risk of STI transmission. However, they are less likely to be willing to use STI-PrEP unless it aligns with their HIV-PrEP dosing regimen, suggesting that research into the safety and efficacy of alternative STI prophylaxis dosing options should be prioritized.

[1]  David Bruce Lewis,et al.  Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. , 2021, The lancet. HIV.

[2]  G. Prestage,et al.  Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia , 2021, AIDS and Behavior.

[3]  R. Guy,et al.  Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men , 2020, JAMA network open.

[4]  L. Degenhardt,et al.  Characteristics of gay and bisexual men who rarely use HIV risk reduction strategies during condomless anal intercourse: Results from the FLUX national online cohort study , 2020, PloS one.

[5]  B. Haire,et al.  Perceptions of sexually transmissible infection pre-exposure prophylaxis: a qualitative study of high-risk gay and bisexual men in Sydney, New South Wales. , 2020, Sexual health.

[6]  A. Burchell,et al.  High Interest in Syphilis Pre-exposure and Post-exposure Prophylaxis Among Gay, Bisexual and Other Men Who Have Sex With Men in Vancouver and Toronto , 2020, Sexually transmitted diseases.

[7]  Denton Callander,et al.  Australian ‘gayborhoods’ and ‘lesborhoods’: a new method for estimating the number and prevalence of adult gay men and lesbian women living in each Australian postcode , 2020, Int. J. Geogr. Inf. Sci..

[8]  L. Degenhardt,et al.  Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine , 2019, AIDS and Behavior.

[9]  J. Kaldor,et al.  Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Fairley,et al.  Use of doxycycline prophylaxis among gay and bisexual men in Melbourne. , 2019, The lancet. HIV.

[11]  Brian L. Price,et al.  Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection , 2019, JAMA.

[12]  J. D. de Wit,et al.  Trends in Attitudes to and the Use of HIV Pre-exposure Prophylaxis by Australian Gay and Bisexual Men, 2011–2017: Implications for Further Implementation from a Diffusion of Innovations Perspective , 2018, AIDS and Behavior.

[13]  W. Mcfarland,et al.  Increases in Pre-exposure Prophylaxis Use and Decreases in Condom Use: Behavioral Patterns Among HIV-Negative San Francisco Men Who have Sex with Men, 2004–2017 , 2018, AIDS and Behavior.

[14]  C. Delaugerre,et al.  Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. , 2017, The Lancet. Infectious diseases.

[15]  Richard Gray,et al.  HIV, viral hepatitis and sexually transmissible infections in Australia , 2016 .

[16]  R. Weiss,et al.  Doxycycline Prophylaxis to Reduce Incident Syphilis among HIV-Infected Men Who Have Sex With Men Who Continue to Engage in High-Risk Sex: A Randomized, Controlled Pilot Study , 2015, Sexually transmitted diseases.

[17]  S. Kippax,et al.  Behavioural surveillance among gay men in Australia: methods, findings and policy implications for the prevention of HIV and other sexually transmissible infections. , 2011, Sexual health.

[18]  J. Kaldor,et al.  Chemoprophylaxis Is Likely to Be Acceptable and Could Mitigate Syphilis Epidemics Among Populations of Gay Men , 2011, Sexually transmitted diseases.

[19]  C. Mcnulty,et al.  Don't wear me out--the public's knowledge of and attitudes to antibiotic use. , 2007, The Journal of antimicrobial chemotherapy.

[20]  J. Kaldor,et al.  Epidemic syphilis among homosexually active men in Sydney , 2005, The Medical journal of Australia.

[21]  K. Holmes,et al.  Effectiveness of condoms in preventing sexually transmitted infections. , 2004, Bulletin of the World Health Organization.

[22]  A. McEwan,et al.  Sexually transmissible infections. , 2001, Australian nursing journal.

[23]  S. Aral,et al.  Sexually Transmitted Disease Clinic Clients at Risk for Subsequent Gonorrhea and Chlamydia Infections: Possible ‘Core’ Transmitters , 2000, Sexually transmitted diseases.